TABLE OF CONTENTS
Volume 10, Issue 4 (June 2004)
Editorial
Editorial: R&D in biotechnology – The management challenges
Simon Shohet
J Commer Biotechnol 10: 301-303; doi:10.1057/palgrave.jcb.3040086
Papers
2003: What lessons for European biotechnology?
M S Fazeli
J Commer Biotechnol 10: 304-311; doi:10.1057/palgrave.jcb.3040087
Biotechnology's special forces: Field-based medical science liaisons
Jane Chin
J Commer Biotechnol 10: 312-318; doi:10.1057/palgrave.jcb.3040088
The class of 2004: Human capital in biotechnology
David Collingham
J Commer Biotechnol 10: 319-322; doi:10.1057/palgrave.jcb.3040089
Encouraging industry participation in the EU's Sixth Framework Programme: Issues, barriers and potential solutions
Wills Hughes-Wilson
J Commer Biotechnol 10: 323-328; doi:10.1057/palgrave.jcb.3040090
Biotech–pharma alliances: Strategies, structures and financing
Tyzoon Tyebjee and Jill Hardin
J Commer Biotechnol 10: 329-339; doi:10.1057/palgrave.jcb.3040091
Biotechnology policy in European countries: An assessment
Bernhard Zechendorf
J Commer Biotechnol 10: 340-351; doi:10.1057/palgrave.jcb.3040092
Singapore's biomedical science sector development strategy: Is it sustainable?
Lisa P L Lim and Michael J Gregory
J Commer Biotechnol 10: 352-362; doi:10.1057/palgrave.jcb.3040093
The market of therapeutic recombinant proteins to 2010
Alex K Pavlou
J Commer Biotechnol 10: 363-367; doi:10.1057/palgrave.jcb.3040094
Miscellaneous
Legal and regulatory update
John Wilkinson and Frederick J Dorey
J Commer Biotechnol 10: 368-382; doi:10.1057/palgrave.jcb.3040095
